featured
Anti-Müllerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-Mullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea
J. Natl. Cancer Inst 2020 Nov 07;[EPub Ahead of Print], KJ Ruddy, DJ Schaid, A Batzler, RS Cecchini, AH Partridge, A Norman, L Fehrenbacher, EA Stewart, E Trabuco, E Ginsburg, FJ Couch, PA Fasching, C Vachon, PA GanzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.